IPG
34
-9
JNPR
50
-6
BEN
50
9
WMB
68
2
TSCO
44
-4
MO
60
-2
THC
60
-5
BK
74
3
ED
45
3
CPB
22
-5
MSFT
48
-9
PCAR
56
-5
AMGN
42
-4
ADP
65
-3
KLAC
38
-6
FOX
51
-6
LH
40
-5
LB
30
4
SYY
49
9
XOM
42
-6
IPG
34
-9
JNPR
50
-6
BEN
50
9
WMB
68
2
TSCO
44
-4
MO
60
-2
THC
60
-5
BK
74
3
ED
45
3
CPB
22
-5
MSFT
48
-9
PCAR
56
-5
AMGN
42
-4
ADP
65
-3
KLAC
38
-6
FOX
51
-6
LH
40
-5
LB
30
4
SYY
49
9
XOM
42
-6
Financhill
Back

Sibanye Stillwater Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
32

SBSW
Sibanye Stillwater

Last Price:
3.98
Seasonality Move:
33.35%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
32
Sibanye Stillwater (SBSW) is a Sell

Is Sibanye Stillwater a Buy, Sell or Hold?

  • The current Sibanye Stillwater [SBSW] share price is $3.98. The Score for SBSW is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • SBSW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SBSW Stock Price Chart

What is Sibanye Stillwater's stock price today?

  • The Sibanye Stillwater share price today is $3.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBSW is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SBSW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 40.08 Sell
Chaikin Money Flow: -2663992 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.12 - 4.88) Sell
Bollinger Bands (100): (3.94 - 4.7) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SBSW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.32 Sell
20-day SMA: 4.59 Sell
50-day SMA: 4.32 Sell
200-day SMA: 4.55 Sell
8-day EMA: 4.24 Sell
20-day EMA: 4.41 Sell
50-day EMA: 4.4 Sell
200-day EMA: 4.71 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Sibanye Stillwater Earnings Growth & SBSW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.11 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Sibanye Stillwater Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):